Results from the study, which focused on gynecological malignant tumors, were presented at the Society for Immunotherapy of ...

More recent acquisitions in 2024—oncology firms Mirati and RayzeBio and neurology firm Karuna—also help support Bristol's strong overall pipeline and wide moat. Bristol has created a strong pipeline ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...